This is the authors' abstract. We don't add key points for this paper.
Human T-cell leukemia virus type I (HTLV-l) is the first human retrovirus to be well established (1, 2) and is associated with a unique T-cell malig nancy-adult T-cell leukemia (ATL) (3). Since the ATL and HTLV-l show the same geographic distribution (4, 5, 6) and patients with ATL are always infected with HTLV-I, it has been expected that HTLV-l would provide a direct clue to understanding the mechanism of tumorigenesis in humans. It was also expected that studies on HTLV-l would provide strategies for diagnosis, treatment, and prevention of ATL. Studies on HTL V-I and the related viruses have progressed rapidly, largely as the result of technologies developed in research on animal retroviruses. New aspects of the retroviruses have been discovered, including a novel mech anism of leukemogenesis. This chapter reviews recent advances in the molecular biology of HTL V -1, focusing on the activation of viral and cellular gene expression.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: